Publications

Michael Shurin

Zakiryanova GK, Kustova E, Urazalieva NT, Baimukhametov ET, Makarov VA, Turaly GM, Shurin GV, Biyasheva ZM, Nakisbekov NN, Shurin MR. Notch signaling defects in NK cells in patients with cancer. Cancer Immunol Immunother. 2021 Apr;70(4):981-988. doi: 10.1007/s00262-020-02763-w. PubMed PMID: 33083905.
Maurer DM, Adamik J, Santos PM, Shi J, Shurin MR, Kirkwood JM, Storkus WJ, Butterfield LH. Dysregulated NF-κB-Dependent ICOSL Expression in Human Dendritic Cell Vaccines Impairs T-cell Responses in Patients with Melanoma. Cancer Immunol Res. 2020 Dec;8(12):1554-1567. doi: 10.1158/2326-6066.CIR-20-0274. PubMed PMID: 33051240; PMCID: PMC8018573.
Shurin GV, Kruglov O, Ding F, Lin Y, Hao X, Keskinov AA, You Z, Lokshin AE, LaFramboise WA, Falo LD Jr, Shurin MR, Bunimovich YL. Melanoma-Induced Reprogramming of Schwann Cell Signaling Aids Tumor Growth. Cancer Res. 2019 May 15;79(10):2736-2747. doi: 10.1158/0008-5472.CAN-18-3872. PubMed PMID: 30914431; PMCID: PMC6522315.
Zakiryanova GK, Kustova E, Urazalieva NT, Baimuchametov ET, Nakisbekov NN, Shurin MR. Abnormal Expression of c-Myc Oncogene in NK Cells in Patients with Cancer. Int J Mol Sci. 2019 Feb 11;20(3): doi: 10.3390/ijms20030756. PubMed PMID: 30754645; PMCID: PMC6387292.
Martyn GV, Shurin GV, Keskinov AA, Bunimovich YL, Shurin MR. Schwann cells shape the neuro-immune environs and control cancer progression. Cancer Immunol Immunother. 2019 Nov;68(11):1819-1829. doi: 10.1007/s00262-018-02296-3. PubMed PMID: 30607548.
Kaplanov I, Carmi Y, Kornetsky R, Shemesh A, Shurin GV, Shurin MR, Dinarello CA, Voronov E, Apte RN. Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation. Proc Natl Acad Sci U S A. 2019 Jan 22;116(4):1361-1369. doi: 10.1073/pnas.1812266115. PubMed PMID: 30545915; PMCID: PMC6347724.
Shurin MR. Immunological targets for cancer therapy: new recognition. Immunotargets Ther. 2018;783-85. doi: 10.2147/ITT.S191821. PubMed PMID: 30538966; PMCID: PMC6254540.
Burkert SC, Shurin GV, White DL, He X, Kapralov AA, Kagan VE, Shurin MR, Star A. Targeting myeloid regulators by paclitaxel-loaded enzymatically degradable nanocups. Nanoscale. 2018 Sep 27;10(37):17990-18000. doi: 10.1039/c8nr04437f. PubMed PMID: 30226240; PMCID: PMC6563927.
Zhou Y, Shurin GV, Zhong H, Bunimovich YL, Han B, Shurin MR. Schwann Cells Augment Cell Spreading and Metastasis of Lung Cancer. Cancer Res. 2018 Oct 15;78(20):5927-5939. doi: 10.1158/0008-5472.CAN-18-1702. PubMed PMID: 30135194.
Zakiryanova GK, Wheeler S, Shurin MR. Oncogenes in immune cells as potential therapeutic targets. Immunotargets Ther. 2018;721-28. doi: 10.2147/ITT.S150586. PubMed PMID: 29692982; PMCID: PMC5903485.
Yanamala N, Kisin ER, Gutkin DW, Shurin MR, Harper M, Shvedova AA. Characterization of pulmonary responses in mice to asbestos/asbestiform fibers using gene expression profiles. J Toxicol Environ Health A. 2018;81(4):60-79. doi: 10.1080/15287394.2017.1408201. PubMed PMID: 29279043.
Anani W, Shurin MR. Targeting Myeloid-Derived Suppressor Cells in Cancer. Adv Exp Med Biol. 2017;1036105-128. doi: 10.1007/978-3-319-67577-0_8. PubMed PMID: 29275468.
Silva GO, Michael ZP, Bian L, Shurin GV, Mulato M, Shurin MR, Star A. Nanoelectronic Discrimination of Nonmalignant and Malignant Cells Using Nanotube Field-Effect Transistors. ACS Sens. 2017 Aug 25;2(8):1128-1132. doi: 10.1021/acssensors.7b00383. PubMed PMID: 28758384; PMCID: PMC6538068.
Zakiryanova GK, Kustova E, Urazalieva NT, Amirbekov A, Baimuchametov ET, Nakisbekov NN, Shurin MR. Alterations of oncogenes expression in NK cells in patients with cancer. Immun Inflamm Dis. 2017 Dec;5(4):493-502. doi: 10.1002/iid3.179. PubMed PMID: 28695716; PMCID: PMC5691306.
Bunimovich YL, Keskinov AA, Shurin GV, Shurin MR. Schwann cells: a new player in the tumor microenvironment. Cancer Immunol Immunother. 2017 Aug;66(8):959-968. doi: 10.1007/s00262-016-1929-z. PubMed PMID: 27885383; PMCID: PMC5509513.
Shurin MR, Ma Y, Keskinov AA, Zhao R, Lokshin A, Agassandian M, Shurin GV. BAFF and APRIL from Activin A-Treated Dendritic Cells Upregulate the Antitumor Efficacy of Dendritic Cells In Vivo. Cancer Res. 2016 Sep 1;76(17):4959-69. doi: 10.1158/0008-5472.CAN-15-2668. PubMed PMID: 27364554; PMCID: PMC5010463.
Keskinov AA, Tapias V, Watkins SC, Ma Y, Shurin MR, Shurin GV. Impact of the Sensory Neurons on Melanoma Growth In Vivo. PLoS One. 2016;11(5):e0156095. doi: 10.1371/journal.pone.0156095. PubMed PMID: 27227315; PMCID: PMC4882065.
Zong J, Keskinov AA, Shurin GV, Shurin MR. Tumor-derived factors modulating dendritic cell function. Cancer Immunol Immunother. 2016 Jul;65(7):821-33. doi: 10.1007/s00262-016-1820-y. PubMed PMID: 26984847.
Aptsiauri N, Jewett A, Hurwitz AA, Shurin MR, Umansky V. Redefining cancer immunotherapy-optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27-30, 2015, Ljubljana, Slovenia. Cancer Immunol Immunother. 2016 Jul;65(7):875-83. doi: 10.1007/s00262-016-1795-8. PubMed PMID: 26810566.
Vlasova II, Kapralov AA, Michael ZP, Burkert SC, Shurin MR, Star A, Shvedova AA, Kagan VE. Enzymatic oxidative biodegradation of nanoparticles: Mechanisms, significance and applications. Toxicol Appl Pharmacol. 2016 May 15;29958-69. doi: 10.1016/j.taap.2016.01.002. PubMed PMID: 26768553; PMCID: PMC4811710.
Dobrovolskaia MA, Shurin M, Shvedova AA. Current understanding of interactions between nanoparticles and the immune system. Toxicol Appl Pharmacol. 2016 May 15;29978-89. doi: 10.1016/j.taap.2015.12.022. PubMed PMID: 26739622; PMCID: PMC4811709.
Seo W, Kapralov AA, Shurin GV, Shurin MR, Kagan VE, Star A. Payload drug vs. nanocarrier biodegradation by myeloperoxidase- and peroxynitrite-mediated oxidations: pharmacokinetic implications. Nanoscale. 2015 May 21;7(19):8689-94. doi: 10.1039/c5nr00251f. PubMed PMID: 25902750; PMCID: PMC4582775.
Shvedova AA, Kisin ER, Yanamala N, Tkach AV, Gutkin DW, Star A, Shurin GV, Kagan VE, Shurin MR. MDSC and TGFβ Are Required for Facilitation of Tumor Growth in the Lungs of Mice Exposed to Carbon Nanotubes. Cancer Res. 2015 Apr 15;75(8):1615-23. doi: 10.1158/0008-5472.CAN-14-2376. PubMed PMID: 25744719; PMCID: PMC4401633.
Anani WQ, Ojerholm E, Shurin MR. Resolving Transferrin Isoforms via Agarose Gel Electrophoresis. Lab Med. 2015 Winter;46(1):26-33. doi: 10.1309/LMVS2JB8JZN8MDVM. PubMed PMID: 25617389.
Agassandian M, Shurin GV, Ma Y, Shurin MR. C-reactive protein and lung diseases. Int J Biochem Cell Biol. 2014 Aug;5377-88. doi: 10.1016/j.biocel.2014.05.016. PubMed PMID: 24853773.

<< Investigators Search

Top